CivaSheet for Pancreatic Cancer
Commercializing CivaSheet for Pancreatic Cancer Patients
This work focuses on making a special radiation sheet called CivaSheet available to help people with pancreatic cancer by delivering radiation directly to the tumor.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Civatech Oncology, INC. NIH-funded |
| Lab location | 1 site (Morrisville, UNITED STATES) |
| Project ID | NIH-11117056 on NIH RePORTER |
What this research studies
CivaSheet is a unique, flexible radiation source that can be placed during surgery for pancreatic cancer. It delivers radiation precisely to the diseased area while protecting nearby healthy tissues. This innovative approach aims to reduce the chance of cancer returning locally and shorten the time between surgery and radiation treatment. Patients in early clinical experiences have shown good recovery without negative effects from the device.
Who could benefit from this research
Good fit: Ideal candidates are patients with pancreatic cancer who are undergoing surgery and could benefit from targeted radiation therapy.
Not a fit: Patients who are not candidates for surgery or whose cancer has spread widely may not directly benefit from this specific treatment.
Why it matters
Potential benefit: If successful, this technology could significantly improve outcomes for pancreatic cancer patients by preventing local recurrence and minimizing side effects from radiation.
How similar studies have performed: This novel, polymer-encapsulated radiation source has already shown success in clinical trials by eliminating local recurrence in pancreatic cancer patients and has received FDA clearance.
Where this research is happening
Morrisville, UNITED STATES
- Civatech Oncology, INC. — Morrisville, United States (Active)
Researchers
- Principal investigator: Perez, Kristy — Civatech Oncology, INC.
- Study coordinator: Perez, Kristy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.